Modeling Structure-Activity Relationship of AMPK Activation

被引:4
作者
Drewe, Jurgen [1 ]
Kuesters, Ernst
Hammann, Felix [2 ]
Kreuter, Matthias [1 ]
Boss, Philipp [3 ]
Schoening, Verena [2 ]
机构
[1] Max Zeller Sohne AG, Med Dept, CH-8590 Romanshorn, Switzerland
[2] Inselspital Univ Hosp, Dept Gen Internal Med, Clin Pharmacol & Toxicol, CH-3012 Bern, Switzerland
[3] Helmholtz Assoc, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
来源
MOLECULES | 2021年 / 26卷 / 21期
关键词
AMPK activator; machine learning; random forest; support vector machine; logistic regression; deep learning; QSAR; PROTEIN-KINASE; IN-VIVO; IDENTIFICATION; METABOLISM; INHIBITORS; REGULATOR; METFORMIN; CANCER; VITRO;
D O I
10.3390/molecules26216508
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adenosine monophosphate activated protein kinase (AMPK) is critical in the regulation of important cellular functions such as lipid, glucose, and protein metabolism; mitochondrial biogenesis and autophagy; and cellular growth. In many diseases-such as metabolic syndrome, obesity, diabetes, and also cancer-activation of AMPK is beneficial. Therefore, there is growing interest in AMPK activators that act either by direct action on the enzyme itself or by indirect activation of upstream regulators. Many natural compounds have been described that activate AMPK indirectly. These compounds are usually contained in mixtures with a variety of structurally different other compounds, which in turn can also alter the activity of AMPK via one or more pathways. For these compounds, experiments are complicated, since the required pure substances are often not yet isolated and/or therefore not sufficiently available. Therefore, our goal was to develop a screening tool that could handle the profound heterogeneity in activation pathways of the AMPK. Since machine learning algorithms can model complex (unknown) relationships and patterns, some of these methods (random forest, support vector machines, stochastic gradient boosting, logistic regression, and deep neural network) were applied and validated using a database, comprising of 904 activating and 799 neutral or inhibiting compounds identified by extensive PubMed literature search and PubChem Bioassay database. All models showed unexpectedly high classification accuracy in training, but more importantly in predicting the unseen test data. These models are therefore suitable tools for rapid in silico screening of established substances or multicomponent mixtures and can be used to identify compounds of interest for further testing.</p>
引用
收藏
页数:12
相关论文
共 40 条
  • [1] Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking
    Balaramnavar, Vishal M.
    Srivastava, Rohit
    Rahuja, Neha
    Gupta, Swati
    Rawat, Arun K.
    Varshney, Salil
    Chandasana, Hardik
    Chhonker, Yashpal S.
    Doharey, Pawan Kumar
    Kumar, Santosh
    Gautam, Sudeep
    Srivastava, Swayam Prakash
    Bhatta, Rabi Sankar
    Saxena, Jitendra Kumar
    Gaikwad, Anil Nilkanth
    Srivastava, Arvind K.
    Saxena, Anil K.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 87 : 578 - 594
  • [2] The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
    Ben Sahra, I.
    Laurent, K.
    Loubat, A.
    Giorgetti-Peraldi, S.
    Colosetti, P.
    Auberger, P.
    Tanti, J. F.
    Le Marchand-Brustel, Y.
    Bost, F.
    [J]. ONCOGENE, 2008, 27 (25) : 3576 - 3586
  • [3] Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
    Ben Sahra, Issam
    Le Marchand-Brustel, Yannick
    Tanti, Jean-Francois
    Bost, Frederic
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1092 - 1099
  • [4] Hypothalamic AMP-activated protein kinase as a mediator of whole body energy balance
    Blanco Martinez de Morentin, Pablo
    Gonzalez, Carmen R.
    Saha, Asisk K.
    Martins, Luis
    Dieguez, Carlos
    Vidal-Puig, Antonio
    Tena-Sempere, Manuel
    Lopez, Miguel
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2011, 12 (03) : 127 - 140
  • [5] Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019
    Cefalu, William T.
    Berg, Erika Gebel
    Saraco, Mindy
    Petersen, Matthew P.
    Uelmen, Sacha
    Robinson, Shamera
    [J]. DIABETES CARE, 2019, 42 : S90 - S102
  • [6] Fan RE, 2008, J MACH LEARN RES, V9, P1871
  • [7] An introduction to ROC analysis
    Fawcett, Tom
    [J]. PATTERN RECOGNITION LETTERS, 2006, 27 (08) : 861 - 874
  • [8] Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1
  • [9] Prediction of Adverse Drug Reactions Using Decision Tree Modeling
    Hammann, F.
    Gutmann, H.
    Vogt, N.
    Helma, C.
    Drewe, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) : 52 - 59
  • [10] Prediction of clinically relevant drug-induced liver injury from structure using machine learning
    Hammann, Felix
    Schoning, Verena
    Drewe, Jurgen
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 2019, 39 (03) : 412 - 419